Overweight or obesity
Clinical trials for Overweight or obesity explained in plain language.
Never miss a new study
Get alerted when new Overweight or obesity trials appear
Sign up with your email to follow new studies for Overweight or obesity, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Fatty liver drug trial halted early: what we know
Disease control Stopped earlyThis early-stage study tested an experimental drug called FT-4101 in 14 overweight or obese adults with NASH, a serious fatty liver disease. The main goals were to check safety and see if the drug could reduce liver fat. The study was stopped early, so results are limited.
Matched conditions: OVERWEIGHT OR OBESITY
Phase 1/2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New obesity drug candidate enters first human tests
Symptom relief Stopped earlyThis early-stage study is testing an experimental drug called LY4064912 in 144 healthy volunteers and people with overweight or obesity. The main goal is to check safety and how the body handles the drug, not yet to prove it works for weight loss. Participants will receive either…
Matched conditions: OVERWEIGHT OR OBESITY
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC